已收录 272983 条政策
 政策提纲
  • 暂无提纲
Separation of Etoricoxib and Its Degradation Products in Drug Substance Using UPLCTM
[摘要] A UPLCTM method was developed and validated for the separation of Etoricoxib and its degradation products in drug substance. The main drug and its seven major and few minor degradation products were well separated within seven minutes on acquity UPLCTM BEH C18 column (1.7 µ, 2.1 x 100 mm) maintained at 25°C, using 0.01M acetate buffer pH 5.0 - acetonitrile (60 : 40, v/v) as mobile phase. The flow rate was 0.3 mL.min-1 and observed backpressure was about 10500 psi. Detection was performed at 235 nm using PDA detector. Linearity was obtained in the concentration range of 0.05 - 120 µg.mL-1. The method was validated for precision, linearity, LOD and LOQ. Stability indicating capability was established by forced degradation experiments.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 分析化学
[关键词] Spectrophotometry; Artesunate; Falcigo; Safranin O; Variamine blue [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文